PharmAthene Company Profile (NYSE:PIP)

Analyst Ratings

Consensus Ratings for PharmAthene (NYSE:PIP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for PharmAthene (NYSE:PIP)
Show:
DateFirmActionRatingPrice TargetActions
8/18/2014Noble FinancialLower Price Target$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014AegisBoost Price Target$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for PharmAthene (NYSE:PIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
3/10/2015($0.03)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014($0.03)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014($0.06)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014($0.06)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q4($0.05)($0.08)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PharmAthene (NYSE:PIP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for PharmAthene (NYSE:PIP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PharmAthene (NYSE:PIP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/13/2016Eric I RichmanDirectorSell329,354$2.20$724,578.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Eric I RichmanDirectorSell11,767$2.20$25,887.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Peter Steven StDirectorBuy25,000$1.65$41,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Linda L ChangCFOSell29,600$2.10$62,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Prescott Group Capital ManagemMajor ShareholderBuy15,000$1.55$23,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PharmAthene (NYSE:PIP)
DateHeadline
07/21/16 06:08 PMPharmAthene, Inc. on Focus After Trading At 52-Week Highs - Press Telegraph
07/19/16 05:38 AMNext Weeks Broker Price Targets For PharmAthene, Inc (PIP) - Fiscal Standard
07/11/16 05:48 PMTop Wall Street Stories: PharmAthene, Inc. (NYSEMKT:PIP), Celadon Group Inc. (NYSE:CGI), AT&T, Inc. (NYSE:T ... - KC Register
07/10/16 05:09 PMOption Market: PharmAthene Inc. Risk Hits An Elevated Level - CML News
07/10/16 05:09 PMPharmAthene, Inc (PIP) Broker Price Targets For The Coming Week - Fiscal Standard
07/08/16 05:52 PMPharmAthene (PIP) Reports $20M Payment from SIGA to Extend Payment Deadline
07/08/16 12:51 PMPharmAthene Receives $20 Million Payment from SIGA to Extend Payment Deadline - [at noodls] - ANNAPOLIS, Md., July 8, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that it has received a $20 million ...
07/07/16 05:54 PMPharmAthene, Inc. Just Reaches 52-Week High? - Press Telegraph
07/01/16 05:52 PMEye Catching Stocks: PharmAthene, Inc. (NYSEMKT:PIP), Xplore Technologies Corp. (NASDAQ:XPLR), Consolidated ... - KC Register
07/01/16 05:34 PMETF’s with exposure to PharmAthene, Inc. : July 1, 2016 -
06/27/16 05:51 PMPharmAthene, Inc. (NYSEMKT:PIP) Set To Join Russell 3000 - Scibility Media
06/25/16 09:35 AMPharmAthene : to Join Russell 3000® and Global Indexes
06/23/16 06:26 PMPharmAthene to Join Russell 3000® and Global Indexes - PR Newswire (press release)
06/23/16 06:26 PMPharmAthene, Inc (PIP) Current Analyst Ratings - Fiscal Standard
06/23/16 03:19 PMPharmAthene to Join Russell 3000® and Global Indexes - [at noodls] - ANNAPOLIS, Md., June 23, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that it is set to join the broad-market ...
06/07/16 03:16 PMPHARMATHENE, INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Se -
06/01/16 06:21 PMPharmAthene, Inc (PIP) Updated Price Targets - FTSE News - PharmAthene, Inc (PIP) Updated Price TargetsFTSE NewsPharmAthene, Inc has a 50 day moving average of 2.32 and a 200 day moving average of 1.88. The stock's market capitalization is 146.92M, it has a 52-week low of 1.20 and a 52-week high of 2.49. The share price of the company (PIP) was up +0.45%, with ...
05/26/16 07:06 PMETF’s with exposure to PharmAthene, Inc. : May 27, 2016 -
05/24/16 10:55 AMPharmAthene, Inc. :PIP-US: Earnings Analysis: Q1, 2016 By the Numbers : May 24, 2016 -
05/17/16 01:56 PMPharmathene Inc (LON:PIP): Stock Sentiment - Wall Street Hints and News - Wall Street Hints and NewsPharmathene Inc (LON:PIP): Stock SentimentWall Street Hints and NewsPharmathene Inc (LON:PIP) institutional sentiment decreased to 1 in Q4 2015. Its down -0.20, from 1.2 in 2015Q3. The ratio fall, as 10 hedge funds opened new and increased stock positions, while 10 decreased and sold stakes in Pharmathene Inc. The ...
05/17/16 12:04 PMPHARMATHENE, INC Financials -
05/12/16 07:53 AMPharmAthene, Inc. (PIP) Short Interest Update - Washington News Wire - Washington News WirePharmAthene, Inc. (PIP) Short Interest UpdateWashington News WirePharmAthene logo PharmAthene, Inc. (NYSE:PIP) was the recipient of a significant drop in short interest during the month of April. As of April 29th, there was short interest totalling 1,547,812 shares, a drop of 8.0% from the April 15th total of 1,683 ...and more »
05/11/16 06:58 AMPharmAthene reports 1Q loss - ANNAPOLIS, Md. (AP) _ PharmAthene Inc. (PIP) on Monday reported a first-quarter loss of $1.2 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Annapolis, Maryland-based company said it had a loss of 2 cents.
05/09/16 04:28 PMPharmAthene Reports First Quarter 2016 Financial and Operational Results - [at noodls] - ANNAPOLIS, Md., May 9, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results ...
05/02/16 07:20 AMPharmAthene, Inc (PIP) Broker Price Targets For The Coming Week - Share Trading News - PharmAthene, Inc (PIP) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of PharmAthene, Inc (PIP). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...
04/29/16 08:04 AMLatest Analyst Ratings For PharmAthene, Inc (PIP) - Share Trading News - Latest Analyst Ratings For PharmAthene, Inc (PIP)Share Trading NewsPharmAthene, Inc has a 50 day moving average of 2.06 and a 200 day moving average of 1.77. The stock's market capitalization is 155.97M, it has a 52-week low of 1.20 and a 52-week high of 2.49. The share price of the company (PIP) was down -1.63%, ...
04/26/16 08:21 AMPerkins Capital Management Inc Lowers stake in PharmAthene (PIP) - Market Digest - Perkins Capital Management Inc Lowers stake in PharmAthene (PIP)Market DigestPharmAthene (PIP) : Perkins Capital Management Inc reduced its stake in PharmAthene by 20.16% during the most recent quarter end. The investment management company now holds a total of 953,800 shares of PharmAthene which is valued at ...
04/25/16 07:59 AMNext Weeks Broker Price Targets For PharmAthene, Inc (PIP) - Share Trading News - Next Weeks Broker Price Targets For PharmAthene, Inc (PIP)Share Trading NewsPharmAthene, Inc has a 50 day moving average of 1.99 and a 200 day moving average of 1.75. The stock's market capitalization is 157.26M, it has a 52-week low of 1.20 and a 52-week high of 2.45. The share price of the company (PIP) was up +1.24%, with ...
04/23/16 07:46 AMBroker Roundup For PharmAthene, Inc (PIP) - Share Trading News - Broker Roundup For PharmAthene, Inc (PIP)Share Trading News08/11/2014 – PharmAthene, Inc had its “buy” rating reiterated by analysts at Aegis Capital. They now have a USD 6 price target on the stock. The share price of PharmAthene, Inc (PIP) was up +0.42% during the last trading session, with a day high of 2.45.
04/22/16 08:31 AMRecent Update on Price Movements: Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) , PharmAthene, Inc (NYSEMKT ... - Street Updates - Recent Update on Price Movements: Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) , PharmAthene, Inc (NYSEMKT ...Street UpdatesIn the past trading session, PharmAthene, Inc (NYSEMKT:PIP) highlighted downward shift of -1.23% or -0.03 points to $2.40. The company traded a volume of 938.11 thousand shares over average volume of 235.71 thousand shares. Trailing twelve month ...and more »
04/19/16 08:47 AMInsider Selling Spotlight: GrubHub Inc (NYSE:GRUB), PharmAthene, Inc. (NYSEMKT:PIP), Liberty Property Trust (NYSE ... - iStreetWire - Insider Selling Spotlight: GrubHub Inc (NYSE:GRUB), PharmAthene, Inc. (NYSEMKT:PIP), Liberty Property Trust (NYSE ...iStreetWireMoving on to the second insider trade which involved RICHMAN ERIC I, a director at PharmAthene, Inc. (NYSEMKT:PIP) sold 329,354 shares at $2.20 per share to trim the total holding at 176,822 shares. Its shares currently owned by company management ...
04/14/16 12:49 PMInsider Selling: PharmAthene, Inc. (PIP) Director Sells $25887.40 in Stock - Washington News Wire - Insider Selling: PharmAthene, Inc. (PIP) Director Sells $25887.40 in StockWashington News WirePharmAthene logo PharmAthene, Inc. (NYSE:PIP) Director Eric I. Richman sold 11,767 shares of the business's stock in a transaction that occurred on Friday, April 8th. The stock was sold at an average price of $2.20, for a total transaction of $25,887.40.
04/14/16 12:49 PMOverview of Stock's Trend: PharmAthene, Inc (NYSEMKT:PIP) , Humana Inc. (NYSE:HUM) - Street Updates - Overview of Stock's Trend: PharmAthene, Inc (NYSEMKT:PIP) , Humana Inc. (NYSE:HUM)Street UpdatesPharmAthene, Inc. (NYSE MKT: PIP) reported recently that the U.S. Bankruptcy Court for the Southern District of New York approved a reorganization plan that lays out the terms and conditions under which SIGA Technologies, Inc. will exit from bankruptcy ...
04/09/16 10:45 AMPharmAthene, Inc. on Focus After Crashing In Today's Session - Business Standard Tribune - PharmAthene, Inc. on Focus After Crashing In Today's SessionBusiness Standard TribuneThe stock of PharmAthene, Inc. (NYSEMKT:PIP) is a huge mover today! The stock decreased 2.73% or $0.06 on April 8, hitting $2.14. About 287,797 shares traded hands or 70.27% up from the average. PharmAthene, Inc. (NYSEMKT:PIP) has risen 52.86% ...and more »
04/07/16 11:54 AMPharmAthene, Inc. (NYSEMKT:PIP)'s Company Shares Increased 22.16% After High Volatility - RiversideGazette.com - PharmAthene, Inc. (NYSEMKT:PIP)'s Company Shares Increased 22.16% After High VolatilityRiversideGazette.comThe shares of PharmAthene, Inc. (NYSEMKT:PIP) increased by 22.16% in the last 20 days and rose 7.94% in the past 5 trading sessions. PharmAthene, Inc. (NYSEMKT:PIP) shares opened at $1.99 in the last session and had intraday high of $2.09 and low of ...Analyst Review: PharmAthene, Inc (PIP)Risers & Fallersall 2 news articles »
04/06/16 01:30 PMBroker Outlook For PharmAthene, Inc (PIP) - Share Trading News - Broker Outlook For PharmAthene, Inc (PIP)Share Trading NewsBroker Outlook For PharmAthene, Inc (PIP). By Brenton Akerman / in US Broker Ratings / on Wednesday, 06 Apr 2016 12:44 PM / 0 Comments. The most recently updated broker views and price targets issued for PharmAthene, Inc (PIP) are below.
04/05/16 12:57 PMAnalyst Review: PharmAthene, Inc (PIP) - Risers & Fallers - Analyst Review: PharmAthene, Inc (PIP)Risers & FallersA number of investment brokers have recently updated their price targets on shares of PharmAthene, Inc (PIP). According to the latest broker reports outstanding on Tuesday 5th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/04/16 02:37 PMETF’s with exposure to PharmAthene, Inc. : April 4, 2016 -
03/30/16 12:42 PMAfter Last Week What Do Analysts Think Of PharmAthene, Inc (PIP) - Share Trading News - After Last Week What Do Analysts Think Of PharmAthene, Inc (PIP)Share Trading News08/11/2014 – PharmAthene, Inc had its “buy” rating reiterated by analysts at Aegis Capital. They now have a USD 6 price target on the stock. The share price of PharmAthene, Inc (PIP) was down -0.51% during the last trading session, with a day high of 2.01.
03/30/16 12:42 PMBroker Changes For PharmAthene, Inc (PIP) - Risers & Fallers - Broker Changes For PharmAthene, Inc (PIP)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of PharmAthene, Inc (PIP). The latest broker reports which are currently outstanding on Wednesday 30th of March state 0 analysts have a rating of “strong buy”, 0 analysts ...
03/25/16 01:27 PMStock Highlights: ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), PharmAthene, Inc. (NYSEMKT:PIP), Barrick Gold ... - KC Register - Stock Highlights: ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), PharmAthene, Inc. (NYSEMKT:PIP), Barrick Gold ...KC RegisterPharmAthene, Inc. (NYSEMKT:PIP) reported its financial and operational results for the year ended December 31, 2015. For the year ended December 31, 2015, PharmAthene's net loss was $3.4 million, or $0.05 per share, compared to a net loss of $10.0 ...and more »
03/25/16 01:27 PMPharmAthene, Inc. (PIP) Short Interest Update - MicroCap Magazine - MicroCap MagazinePharmAthene, Inc. (PIP) Short Interest UpdateMicroCap MagazinePharmAthene logo PharmAthene, Inc. (NYSE:PIP) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,763,409 shares, a drop of 5.1% from the February 29th total of 1,858,982 shares ...Changes To Broker Targets On PharmAthene, Inc (PIP)Share Trading NewsPharmathene Incorporated (NYSEMKT:PIP) Shorts Decreased by 1.26% After Short CoveringRiversideGazette.comall 3 news articles »
03/23/16 02:30 PMETF’s with exposure to PharmAthene, Inc. : March 23, 2016 -
03/23/16 10:44 AMPharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/22/16 02:07 PMPharmAthene, Inc. :PIP-US: Earnings Analysis: 2015 By the Numbers -
03/21/16 02:00 PMPharmathene Incorporated (NYSEMKT:PIP) Shorts Decreased by 1.26% After Short Covering - Stock Caller - Pharmathene Incorporated (NYSEMKT:PIP) Shorts Decreased by 1.26% After Short CoveringStock CallerThe short interest to Pharmathene Incorporated's float is 3.92%. The stock decreased 1.70% or $0.03 on March 18, hitting $1.73. About 44,248 shares traded hands. PharmAthene, Inc. (NYSEMKT:PIP) has risen 8.81% since August 13, 2015 and is uptrending.
03/17/16 12:20 PMPharmathene Incorporated (NYSEMKT:PIP) Short Interest Decreased By 1.26% - Clinton Financial - Pharmathene Incorporated (NYSEMKT:PIP) Short Interest Decreased By 1.26%Clinton FinancialThe short interest to Pharmathene Incorporated's float is 3.92%. The stock increased 1.73% or $0.03 on March 16, hitting $1.76. About 176,526 shares traded hands. PharmAthene, Inc. (NYSEMKT:PIP) has risen 12.10% since August 11, 2015 and is ...
03/14/16 06:00 AMAnalysis and PharmAthene, Inc. (PIP) Earnings Review - OctaFinance.com - Analysis and PharmAthene, Inc. (PIP) Earnings ReviewOctaFinance.comAnalysts await PharmAthene, Inc. (NYSEMKT:PIP) to reports earnings on March, 14. The stock increased 2.96% or $0.05 on March 11, hitting $1.74. About 144,741 shares traded hands. PharmAthene, Inc. (NYSEMKT:PIP) has risen 10.13% since August 6, ...and more »
03/11/16 03:53 PMPHARMATHENE, INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exhibi -
03/11/16 03:30 PM/C O R R E C T I O N -- PharmAthene, Inc./ - [PR Newswire] - In the news release, PharmAthene Reports Year-End 2015 Financial and Operational Results; Provides Update on Litigation with SIGA, issued March 11, 2016 by PharmAthene, Inc. over PR Newswire, we are advised ...

Social

About PharmAthene

Pharmathene, Inc. (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PIP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.53
  • 50 Day Moving Average: $2.38
  • 200 Day Moving Average: $2.06
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $167.26M
  • Current Year EPS Consensus Estimate: $-0.10 EPS
  • Next Year EPS Consensus Estimate: $-0.07 EPS
Additional Links:
PharmAthene (NYSE:PIP) Chart for Tuesday, July, 26, 2016